nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—myometrium—ovarian cancer	0.0143	0.0708	CbGeAlD
Brimonidine—AOX1—uterine cervix—ovarian cancer	0.0112	0.0551	CbGeAlD
Brimonidine—AOX1—decidua—ovarian cancer	0.0106	0.0525	CbGeAlD
Brimonidine—AOX1—endometrium—ovarian cancer	0.0101	0.0498	CbGeAlD
Brimonidine—AOX1—gonad—ovarian cancer	0.00935	0.0462	CbGeAlD
Brimonidine—AOX1—uterus—ovarian cancer	0.00929	0.0459	CbGeAlD
Brimonidine—ADRA2C—myometrium—ovarian cancer	0.00906	0.0448	CbGeAlD
Brimonidine—AOX1—female reproductive system—ovarian cancer	0.00835	0.0413	CbGeAlD
Brimonidine—AOX1—female gonad—ovarian cancer	0.0076	0.0376	CbGeAlD
Brimonidine—AOX1—vagina—ovarian cancer	0.00756	0.0373	CbGeAlD
Brimonidine—ADRA2A—myometrium—ovarian cancer	0.00723	0.0357	CbGeAlD
Brimonidine—ADRA2C—uterine cervix—ovarian cancer	0.00705	0.0348	CbGeAlD
Brimonidine—AOX1—testis—ovarian cancer	0.00674	0.0333	CbGeAlD
Brimonidine—ADRA2C—decidua—ovarian cancer	0.00672	0.0332	CbGeAlD
Brimonidine—ADRA2C—endometrium—ovarian cancer	0.00638	0.0315	CbGeAlD
Brimonidine—ADRA2C—uterus—ovarian cancer	0.00587	0.029	CbGeAlD
Brimonidine—ADRA2A—uterine cervix—ovarian cancer	0.00562	0.0278	CbGeAlD
Brimonidine—ADRA2A—decidua—ovarian cancer	0.00536	0.0265	CbGeAlD
Brimonidine—ADRA2A—endometrium—ovarian cancer	0.00509	0.0251	CbGeAlD
Brimonidine—AOX1—lymph node—ovarian cancer	0.00489	0.0241	CbGeAlD
Brimonidine—ADRA2C—female gonad—ovarian cancer	0.00481	0.0237	CbGeAlD
Brimonidine—ADRA2C—vagina—ovarian cancer	0.00478	0.0236	CbGeAlD
Brimonidine—ADRA2A—gonad—ovarian cancer	0.00472	0.0233	CbGeAlD
Brimonidine—ADRA2A—uterus—ovarian cancer	0.00469	0.0232	CbGeAlD
Brimonidine—ADRA2C—testis—ovarian cancer	0.00426	0.0211	CbGeAlD
Brimonidine—ADRA2A—female reproductive system—ovarian cancer	0.00421	0.0208	CbGeAlD
Brimonidine—ADRA2A—female gonad—ovarian cancer	0.00383	0.0189	CbGeAlD
Brimonidine—ADRA2A—vagina—ovarian cancer	0.00381	0.0188	CbGeAlD
Brimonidine—ADRA2A—testis—ovarian cancer	0.0034	0.0168	CbGeAlD
Brimonidine—ADRA2C—lymph node—ovarian cancer	0.00309	0.0153	CbGeAlD
Brimonidine—ADRA2A—lymph node—ovarian cancer	0.00247	0.0122	CbGeAlD
Brimonidine—Diabetes mellitus—Epirubicin—ovarian cancer	0.00167	0.0021	CcSEcCtD
Brimonidine—Paraesthesia—Vinorelbine—ovarian cancer	0.00167	0.0021	CcSEcCtD
Brimonidine—Dyspnoea—Vinorelbine—ovarian cancer	0.00166	0.00208	CcSEcCtD
Brimonidine—Eye disorder—Paclitaxel—ovarian cancer	0.00165	0.00206	CcSEcCtD
Brimonidine—Flushing—Paclitaxel—ovarian cancer	0.00164	0.00205	CcSEcCtD
Brimonidine—Cardiac disorder—Paclitaxel—ovarian cancer	0.00164	0.00205	CcSEcCtD
Brimonidine—Abnormal vision—Doxorubicin—ovarian cancer	0.00162	0.00203	CcSEcCtD
Brimonidine—Conjunctivitis—Docetaxel—ovarian cancer	0.00162	0.00203	CcSEcCtD
Brimonidine—Eye pain—Epirubicin—ovarian cancer	0.00161	0.00202	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00161	0.00201	CcSEcCtD
Brimonidine—Fatigue—Vinorelbine—ovarian cancer	0.0016	0.00201	CcSEcCtD
Brimonidine—Hypersensitivity—Topotecan—ovarian cancer	0.0016	0.00201	CcSEcCtD
Brimonidine—Angiopathy—Paclitaxel—ovarian cancer	0.0016	0.002	CcSEcCtD
Brimonidine—Pain—Vinorelbine—ovarian cancer	0.00159	0.002	CcSEcCtD
Brimonidine—Immune system disorder—Paclitaxel—ovarian cancer	0.00159	0.002	CcSEcCtD
Brimonidine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00159	0.00199	CcSEcCtD
Brimonidine—Arrhythmia—Paclitaxel—ovarian cancer	0.00157	0.00197	CcSEcCtD
Brimonidine—Hypersensitivity—Melphalan—ovarian cancer	0.00157	0.00197	CcSEcCtD
Brimonidine—Asthenia—Topotecan—ovarian cancer	0.00156	0.00196	CcSEcCtD
Brimonidine—Diabetes mellitus—Doxorubicin—ovarian cancer	0.00155	0.00194	CcSEcCtD
Brimonidine—Mental disorder—Paclitaxel—ovarian cancer	0.00154	0.00194	CcSEcCtD
Brimonidine—Pruritus—Topotecan—ovarian cancer	0.00154	0.00193	CcSEcCtD
Brimonidine—Erythema—Paclitaxel—ovarian cancer	0.00153	0.00192	CcSEcCtD
Brimonidine—Asthenia—Melphalan—ovarian cancer	0.00153	0.00192	CcSEcCtD
Brimonidine—Pruritus—Melphalan—ovarian cancer	0.00151	0.00189	CcSEcCtD
Brimonidine—Dysgeusia—Paclitaxel—ovarian cancer	0.0015	0.00188	CcSEcCtD
Brimonidine—Rhinitis—Docetaxel—ovarian cancer	0.0015	0.00188	CcSEcCtD
Brimonidine—Eye pain—Doxorubicin—ovarian cancer	0.00149	0.00187	CcSEcCtD
Brimonidine—Lethargy—Epirubicin—ovarian cancer	0.00149	0.00186	CcSEcCtD
Brimonidine—Pharyngitis—Docetaxel—ovarian cancer	0.00148	0.00186	CcSEcCtD
Brimonidine—Osteoarthritis—Epirubicin—ovarian cancer	0.00146	0.00183	CcSEcCtD
Brimonidine—Nausea—Chlorambucil—ovarian cancer	0.00145	0.00182	CcSEcCtD
Brimonidine—Vision blurred—Paclitaxel—ovarian cancer	0.00145	0.00181	CcSEcCtD
Brimonidine—Visual impairment—Docetaxel—ovarian cancer	0.00144	0.0018	CcSEcCtD
Brimonidine—Dizziness—Topotecan—ovarian cancer	0.00144	0.0018	CcSEcCtD
Brimonidine—Face oedema—Epirubicin—ovarian cancer	0.00141	0.00176	CcSEcCtD
Brimonidine—Eye disorder—Docetaxel—ovarian cancer	0.0014	0.00175	CcSEcCtD
Brimonidine—Flushing—Docetaxel—ovarian cancer	0.00139	0.00174	CcSEcCtD
Brimonidine—Cardiac disorder—Docetaxel—ovarian cancer	0.00139	0.00174	CcSEcCtD
Brimonidine—Syncope—Paclitaxel—ovarian cancer	0.00138	0.00172	CcSEcCtD
Brimonidine—Lethargy—Doxorubicin—ovarian cancer	0.00137	0.00172	CcSEcCtD
Brimonidine—Rash—Topotecan—ovarian cancer	0.00137	0.00172	CcSEcCtD
Brimonidine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00137	0.00172	CcSEcCtD
Brimonidine—Dermatitis—Topotecan—ovarian cancer	0.00137	0.00172	CcSEcCtD
Brimonidine—Headache—Topotecan—ovarian cancer	0.00136	0.00171	CcSEcCtD
Brimonidine—Palpitations—Paclitaxel—ovarian cancer	0.00136	0.0017	CcSEcCtD
Brimonidine—Angiopathy—Docetaxel—ovarian cancer	0.00135	0.0017	CcSEcCtD
Brimonidine—Immune system disorder—Docetaxel—ovarian cancer	0.00135	0.00169	CcSEcCtD
Brimonidine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00135	0.00169	CcSEcCtD
Brimonidine—Osteoarthritis—Doxorubicin—ovarian cancer	0.00135	0.00169	CcSEcCtD
Brimonidine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00135	0.00169	CcSEcCtD
Brimonidine—Rash—Melphalan—ovarian cancer	0.00134	0.00168	CcSEcCtD
Brimonidine—Dermatitis—Melphalan—ovarian cancer	0.00134	0.00168	CcSEcCtD
Brimonidine—Cough—Paclitaxel—ovarian cancer	0.00134	0.00168	CcSEcCtD
Brimonidine—Asthenia—Vinorelbine—ovarian cancer	0.00134	0.00167	CcSEcCtD
Brimonidine—Dry skin—Epirubicin—ovarian cancer	0.00133	0.00167	CcSEcCtD
Brimonidine—Arrhythmia—Docetaxel—ovarian cancer	0.00133	0.00167	CcSEcCtD
Brimonidine—Hypertension—Paclitaxel—ovarian cancer	0.00132	0.00166	CcSEcCtD
Brimonidine—Pruritus—Vinorelbine—ovarian cancer	0.00132	0.00165	CcSEcCtD
Brimonidine—Mental disorder—Docetaxel—ovarian cancer	0.00131	0.00164	CcSEcCtD
Brimonidine—Arthralgia—Paclitaxel—ovarian cancer	0.00131	0.00164	CcSEcCtD
Brimonidine—Chest pain—Paclitaxel—ovarian cancer	0.00131	0.00164	CcSEcCtD
Brimonidine—Myalgia—Paclitaxel—ovarian cancer	0.00131	0.00164	CcSEcCtD
Brimonidine—Nasopharyngitis—Epirubicin—ovarian cancer	0.0013	0.00163	CcSEcCtD
Brimonidine—Anxiety—Paclitaxel—ovarian cancer	0.0013	0.00163	CcSEcCtD
Brimonidine—Face oedema—Doxorubicin—ovarian cancer	0.0013	0.00163	CcSEcCtD
Brimonidine—Erythema—Docetaxel—ovarian cancer	0.0013	0.00163	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.0013	0.00163	CcSEcCtD
Brimonidine—Nausea—Topotecan—ovarian cancer	0.00129	0.00162	CcSEcCtD
Brimonidine—Discomfort—Paclitaxel—ovarian cancer	0.00129	0.00162	CcSEcCtD
Brimonidine—Dry mouth—Paclitaxel—ovarian cancer	0.00128	0.0016	CcSEcCtD
Brimonidine—Dysgeusia—Docetaxel—ovarian cancer	0.00127	0.0016	CcSEcCtD
Brimonidine—Nausea—Melphalan—ovarian cancer	0.00127	0.00159	CcSEcCtD
Brimonidine—Influenza—Epirubicin—ovarian cancer	0.00126	0.00158	CcSEcCtD
Brimonidine—Oedema—Paclitaxel—ovarian cancer	0.00125	0.00157	CcSEcCtD
Brimonidine—Infection—Paclitaxel—ovarian cancer	0.00124	0.00156	CcSEcCtD
Brimonidine—Dry skin—Doxorubicin—ovarian cancer	0.00123	0.00155	CcSEcCtD
Brimonidine—Shock—Paclitaxel—ovarian cancer	0.00123	0.00154	CcSEcCtD
Brimonidine—Dizziness—Vinorelbine—ovarian cancer	0.00123	0.00154	CcSEcCtD
Brimonidine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00123	0.00154	CcSEcCtD
Brimonidine—Tachycardia—Paclitaxel—ovarian cancer	0.00122	0.00153	CcSEcCtD
Brimonidine—Skin disorder—Paclitaxel—ovarian cancer	0.00122	0.00152	CcSEcCtD
Brimonidine—Bronchitis—Epirubicin—ovarian cancer	0.00121	0.00152	CcSEcCtD
Brimonidine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.0012	0.00151	CcSEcCtD
Brimonidine—Rash—Vinorelbine—ovarian cancer	0.00117	0.00147	CcSEcCtD
Brimonidine—Dermatitis—Vinorelbine—ovarian cancer	0.00117	0.00147	CcSEcCtD
Brimonidine—Hypotension—Paclitaxel—ovarian cancer	0.00117	0.00147	CcSEcCtD
Brimonidine—Headache—Vinorelbine—ovarian cancer	0.00117	0.00146	CcSEcCtD
Brimonidine—Syncope—Docetaxel—ovarian cancer	0.00117	0.00146	CcSEcCtD
Brimonidine—Influenza—Doxorubicin—ovarian cancer	0.00116	0.00146	CcSEcCtD
Brimonidine—Palpitations—Docetaxel—ovarian cancer	0.00115	0.00144	CcSEcCtD
Brimonidine—Loss of consciousness—Docetaxel—ovarian cancer	0.00114	0.00143	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00114	0.00143	CcSEcCtD
Brimonidine—Cough—Docetaxel—ovarian cancer	0.00113	0.00142	CcSEcCtD
Brimonidine—Insomnia—Paclitaxel—ovarian cancer	0.00113	0.00142	CcSEcCtD
Brimonidine—Paraesthesia—Paclitaxel—ovarian cancer	0.00112	0.00141	CcSEcCtD
Brimonidine—Hypertension—Docetaxel—ovarian cancer	0.00112	0.00141	CcSEcCtD
Brimonidine—Drowsiness—Epirubicin—ovarian cancer	0.00112	0.00141	CcSEcCtD
Brimonidine—Bronchitis—Doxorubicin—ovarian cancer	0.00112	0.0014	CcSEcCtD
Brimonidine—Dyspnoea—Paclitaxel—ovarian cancer	0.00112	0.0014	CcSEcCtD
Brimonidine—Somnolence—Paclitaxel—ovarian cancer	0.00111	0.0014	CcSEcCtD
Brimonidine—Chest pain—Docetaxel—ovarian cancer	0.00111	0.00139	CcSEcCtD
Brimonidine—Myalgia—Docetaxel—ovarian cancer	0.00111	0.00139	CcSEcCtD
Brimonidine—Arthralgia—Docetaxel—ovarian cancer	0.00111	0.00139	CcSEcCtD
Brimonidine—Nausea—Vinorelbine—ovarian cancer	0.00111	0.00139	CcSEcCtD
Brimonidine—Dyspepsia—Paclitaxel—ovarian cancer	0.0011	0.00138	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.0011	0.00138	CcSEcCtD
Brimonidine—Conjunctivitis—Epirubicin—ovarian cancer	0.00109	0.00137	CcSEcCtD
Brimonidine—Dry mouth—Docetaxel—ovarian cancer	0.00108	0.00136	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00108	0.00135	CcSEcCtD
Brimonidine—Fatigue—Paclitaxel—ovarian cancer	0.00108	0.00135	CcSEcCtD
Brimonidine—Pain—Paclitaxel—ovarian cancer	0.00107	0.00134	CcSEcCtD
Brimonidine—Oedema—Docetaxel—ovarian cancer	0.00106	0.00133	CcSEcCtD
Brimonidine—Infection—Docetaxel—ovarian cancer	0.00105	0.00132	CcSEcCtD
Brimonidine—Sinusitis—Epirubicin—ovarian cancer	0.00105	0.00132	CcSEcCtD
Brimonidine—Shock—Docetaxel—ovarian cancer	0.00104	0.00131	CcSEcCtD
Brimonidine—Nervous system disorder—Docetaxel—ovarian cancer	0.00104	0.0013	CcSEcCtD
Brimonidine—Drowsiness—Doxorubicin—ovarian cancer	0.00104	0.0013	CcSEcCtD
Brimonidine—Tachycardia—Docetaxel—ovarian cancer	0.00104	0.0013	CcSEcCtD
Brimonidine—Skin disorder—Docetaxel—ovarian cancer	0.00103	0.00129	CcSEcCtD
Brimonidine—Bradycardia—Epirubicin—ovarian cancer	0.00103	0.00129	CcSEcCtD
Brimonidine—Rhinitis—Epirubicin—ovarian cancer	0.00101	0.00127	CcSEcCtD
Brimonidine—Conjunctivitis—Doxorubicin—ovarian cancer	0.00101	0.00127	CcSEcCtD
Brimonidine—Pharyngitis—Epirubicin—ovarian cancer	0.001	0.00125	CcSEcCtD
Brimonidine—Hypotension—Docetaxel—ovarian cancer	0.000991	0.00124	CcSEcCtD
Brimonidine—Sinusitis—Doxorubicin—ovarian cancer	0.000974	0.00122	CcSEcCtD
Brimonidine—Visual impairment—Epirubicin—ovarian cancer	0.000971	0.00122	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000967	0.00121	CcSEcCtD
Brimonidine—Insomnia—Docetaxel—ovarian cancer	0.00096	0.0012	CcSEcCtD
Brimonidine—Paraesthesia—Docetaxel—ovarian cancer	0.000953	0.00119	CcSEcCtD
Brimonidine—Bradycardia—Doxorubicin—ovarian cancer	0.000949	0.00119	CcSEcCtD
Brimonidine—Dyspnoea—Docetaxel—ovarian cancer	0.000946	0.00119	CcSEcCtD
Brimonidine—Somnolence—Docetaxel—ovarian cancer	0.000943	0.00118	CcSEcCtD
Brimonidine—Eye disorder—Epirubicin—ovarian cancer	0.000941	0.00118	CcSEcCtD
Brimonidine—Flushing—Epirubicin—ovarian cancer	0.000935	0.00117	CcSEcCtD
Brimonidine—Cardiac disorder—Epirubicin—ovarian cancer	0.000935	0.00117	CcSEcCtD
Brimonidine—Rhinitis—Doxorubicin—ovarian cancer	0.000934	0.00117	CcSEcCtD
Brimonidine—Dyspepsia—Docetaxel—ovarian cancer	0.000934	0.00117	CcSEcCtD
Brimonidine—Pharyngitis—Doxorubicin—ovarian cancer	0.000925	0.00116	CcSEcCtD
Brimonidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000922	0.00116	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000916	0.00115	CcSEcCtD
Brimonidine—Fatigue—Docetaxel—ovarian cancer	0.000915	0.00115	CcSEcCtD
Brimonidine—Angiopathy—Epirubicin—ovarian cancer	0.000914	0.00115	CcSEcCtD
Brimonidine—Immune system disorder—Epirubicin—ovarian cancer	0.00091	0.00114	CcSEcCtD
Brimonidine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000908	0.00114	CcSEcCtD
Brimonidine—Pain—Docetaxel—ovarian cancer	0.000907	0.00114	CcSEcCtD
Brimonidine—Arrhythmia—Epirubicin—ovarian cancer	0.0009	0.00113	CcSEcCtD
Brimonidine—Visual impairment—Doxorubicin—ovarian cancer	0.000898	0.00113	CcSEcCtD
Brimonidine—Asthenia—Paclitaxel—ovarian cancer	0.000898	0.00113	CcSEcCtD
Brimonidine—Pruritus—Paclitaxel—ovarian cancer	0.000886	0.00111	CcSEcCtD
Brimonidine—Mental disorder—Epirubicin—ovarian cancer	0.000882	0.00111	CcSEcCtD
Brimonidine—Erythema—Epirubicin—ovarian cancer	0.000877	0.0011	CcSEcCtD
Brimonidine—Eye disorder—Doxorubicin—ovarian cancer	0.000871	0.00109	CcSEcCtD
Brimonidine—Flushing—Doxorubicin—ovarian cancer	0.000865	0.00108	CcSEcCtD
Brimonidine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000865	0.00108	CcSEcCtD
Brimonidine—Dysgeusia—Epirubicin—ovarian cancer	0.000859	0.00108	CcSEcCtD
Brimonidine—Angiopathy—Doxorubicin—ovarian cancer	0.000846	0.00106	CcSEcCtD
Brimonidine—Immune system disorder—Doxorubicin—ovarian cancer	0.000842	0.00106	CcSEcCtD
Brimonidine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00084	0.00105	CcSEcCtD
Brimonidine—Arrhythmia—Doxorubicin—ovarian cancer	0.000833	0.00104	CcSEcCtD
Brimonidine—Dizziness—Paclitaxel—ovarian cancer	0.000828	0.00104	CcSEcCtD
Brimonidine—Vision blurred—Epirubicin—ovarian cancer	0.000826	0.00104	CcSEcCtD
Brimonidine—Mental disorder—Doxorubicin—ovarian cancer	0.000817	0.00102	CcSEcCtD
Brimonidine—Erythema—Doxorubicin—ovarian cancer	0.000811	0.00102	CcSEcCtD
Brimonidine—Dysgeusia—Doxorubicin—ovarian cancer	0.000795	0.000996	CcSEcCtD
Brimonidine—Rash—Paclitaxel—ovarian cancer	0.000789	0.00099	CcSEcCtD
Brimonidine—Dermatitis—Paclitaxel—ovarian cancer	0.000789	0.000989	CcSEcCtD
Brimonidine—Syncope—Epirubicin—ovarian cancer	0.000786	0.000986	CcSEcCtD
Brimonidine—Headache—Paclitaxel—ovarian cancer	0.000784	0.000983	CcSEcCtD
Brimonidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000782	0.00098	CcSEcCtD
Brimonidine—Palpitations—Epirubicin—ovarian cancer	0.000775	0.000972	CcSEcCtD
Brimonidine—Loss of consciousness—Epirubicin—ovarian cancer	0.000771	0.000966	CcSEcCtD
Brimonidine—Cough—Epirubicin—ovarian cancer	0.000765	0.000959	CcSEcCtD
Brimonidine—Vision blurred—Doxorubicin—ovarian cancer	0.000765	0.000959	CcSEcCtD
Brimonidine—Asthenia—Docetaxel—ovarian cancer	0.000761	0.000954	CcSEcCtD
Brimonidine—Hypertension—Epirubicin—ovarian cancer	0.000757	0.000949	CcSEcCtD
Brimonidine—Pruritus—Docetaxel—ovarian cancer	0.000751	0.000941	CcSEcCtD
Brimonidine—Chest pain—Epirubicin—ovarian cancer	0.000747	0.000936	CcSEcCtD
Brimonidine—Arthralgia—Epirubicin—ovarian cancer	0.000747	0.000936	CcSEcCtD
Brimonidine—Myalgia—Epirubicin—ovarian cancer	0.000747	0.000936	CcSEcCtD
Brimonidine—Anxiety—Epirubicin—ovarian cancer	0.000744	0.000933	CcSEcCtD
Brimonidine—Nausea—Paclitaxel—ovarian cancer	0.000744	0.000932	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000741	0.000929	CcSEcCtD
Brimonidine—Discomfort—Epirubicin—ovarian cancer	0.000738	0.000925	CcSEcCtD
Brimonidine—Dry mouth—Epirubicin—ovarian cancer	0.00073	0.000915	CcSEcCtD
Brimonidine—Syncope—Doxorubicin—ovarian cancer	0.000728	0.000912	CcSEcCtD
Brimonidine—Palpitations—Doxorubicin—ovarian cancer	0.000717	0.000899	CcSEcCtD
Brimonidine—Oedema—Epirubicin—ovarian cancer	0.000716	0.000897	CcSEcCtD
Brimonidine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000713	0.000894	CcSEcCtD
Brimonidine—Infection—Epirubicin—ovarian cancer	0.000711	0.000891	CcSEcCtD
Brimonidine—Cough—Doxorubicin—ovarian cancer	0.000708	0.000888	CcSEcCtD
Brimonidine—Shock—Epirubicin—ovarian cancer	0.000704	0.000883	CcSEcCtD
Brimonidine—Nervous system disorder—Epirubicin—ovarian cancer	0.000702	0.00088	CcSEcCtD
Brimonidine—Dizziness—Docetaxel—ovarian cancer	0.000702	0.00088	CcSEcCtD
Brimonidine—Hypertension—Doxorubicin—ovarian cancer	0.0007	0.000878	CcSEcCtD
Brimonidine—Tachycardia—Epirubicin—ovarian cancer	0.000698	0.000876	CcSEcCtD
Brimonidine—Skin disorder—Epirubicin—ovarian cancer	0.000695	0.000871	CcSEcCtD
Brimonidine—Myalgia—Doxorubicin—ovarian cancer	0.000691	0.000866	CcSEcCtD
Brimonidine—Arthralgia—Doxorubicin—ovarian cancer	0.000691	0.000866	CcSEcCtD
Brimonidine—Chest pain—Doxorubicin—ovarian cancer	0.000691	0.000866	CcSEcCtD
Brimonidine—Anxiety—Doxorubicin—ovarian cancer	0.000688	0.000863	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000686	0.00086	CcSEcCtD
Brimonidine—Discomfort—Doxorubicin—ovarian cancer	0.000682	0.000856	CcSEcCtD
Brimonidine—Dry mouth—Doxorubicin—ovarian cancer	0.000676	0.000847	CcSEcCtD
Brimonidine—Rash—Docetaxel—ovarian cancer	0.000669	0.000839	CcSEcCtD
Brimonidine—Hypotension—Epirubicin—ovarian cancer	0.000669	0.000838	CcSEcCtD
Brimonidine—Dermatitis—Docetaxel—ovarian cancer	0.000668	0.000838	CcSEcCtD
Brimonidine—Headache—Docetaxel—ovarian cancer	0.000665	0.000833	CcSEcCtD
Brimonidine—Oedema—Doxorubicin—ovarian cancer	0.000662	0.00083	CcSEcCtD
Brimonidine—Infection—Doxorubicin—ovarian cancer	0.000658	0.000825	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000652	0.000817	CcSEcCtD
Brimonidine—Shock—Doxorubicin—ovarian cancer	0.000651	0.000817	CcSEcCtD
Brimonidine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000649	0.000814	CcSEcCtD
Brimonidine—Insomnia—Epirubicin—ovarian cancer	0.000647	0.000811	CcSEcCtD
Brimonidine—Tachycardia—Doxorubicin—ovarian cancer	0.000646	0.00081	CcSEcCtD
Brimonidine—Skin disorder—Doxorubicin—ovarian cancer	0.000643	0.000806	CcSEcCtD
Brimonidine—Paraesthesia—Epirubicin—ovarian cancer	0.000643	0.000806	CcSEcCtD
Brimonidine—Dyspnoea—Epirubicin—ovarian cancer	0.000638	0.0008	CcSEcCtD
Brimonidine—Somnolence—Epirubicin—ovarian cancer	0.000636	0.000798	CcSEcCtD
Brimonidine—Nausea—Docetaxel—ovarian cancer	0.00063	0.00079	CcSEcCtD
Brimonidine—Dyspepsia—Epirubicin—ovarian cancer	0.00063	0.00079	CcSEcCtD
Brimonidine—Hypotension—Doxorubicin—ovarian cancer	0.000619	0.000776	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000618	0.000775	CcSEcCtD
Brimonidine—Fatigue—Epirubicin—ovarian cancer	0.000617	0.000774	CcSEcCtD
Brimonidine—Pain—Epirubicin—ovarian cancer	0.000612	0.000767	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000603	0.000756	CcSEcCtD
Brimonidine—Insomnia—Doxorubicin—ovarian cancer	0.000599	0.000751	CcSEcCtD
Brimonidine—Paraesthesia—Doxorubicin—ovarian cancer	0.000595	0.000745	CcSEcCtD
Brimonidine—Dyspnoea—Doxorubicin—ovarian cancer	0.00059	0.00074	CcSEcCtD
Brimonidine—Somnolence—Doxorubicin—ovarian cancer	0.000589	0.000738	CcSEcCtD
Brimonidine—Dyspepsia—Doxorubicin—ovarian cancer	0.000583	0.000731	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000572	0.000717	CcSEcCtD
Brimonidine—Fatigue—Doxorubicin—ovarian cancer	0.000571	0.000716	CcSEcCtD
Brimonidine—Pain—Doxorubicin—ovarian cancer	0.000566	0.00071	CcSEcCtD
Brimonidine—Hypersensitivity—Epirubicin—ovarian cancer	0.000527	0.000661	CcSEcCtD
Brimonidine—Asthenia—Epirubicin—ovarian cancer	0.000513	0.000644	CcSEcCtD
Brimonidine—Pruritus—Epirubicin—ovarian cancer	0.000506	0.000635	CcSEcCtD
Brimonidine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000488	0.000612	CcSEcCtD
Brimonidine—Asthenia—Doxorubicin—ovarian cancer	0.000475	0.000596	CcSEcCtD
Brimonidine—Dizziness—Epirubicin—ovarian cancer	0.000473	0.000593	CcSEcCtD
Brimonidine—Pruritus—Doxorubicin—ovarian cancer	0.000468	0.000587	CcSEcCtD
Brimonidine—Rash—Epirubicin—ovarian cancer	0.000451	0.000566	CcSEcCtD
Brimonidine—Dermatitis—Epirubicin—ovarian cancer	0.000451	0.000565	CcSEcCtD
Brimonidine—Headache—Epirubicin—ovarian cancer	0.000448	0.000562	CcSEcCtD
Brimonidine—Dizziness—Doxorubicin—ovarian cancer	0.000438	0.000549	CcSEcCtD
Brimonidine—Nausea—Epirubicin—ovarian cancer	0.000425	0.000533	CcSEcCtD
Brimonidine—Rash—Doxorubicin—ovarian cancer	0.000417	0.000523	CcSEcCtD
Brimonidine—Dermatitis—Doxorubicin—ovarian cancer	0.000417	0.000523	CcSEcCtD
Brimonidine—Headache—Doxorubicin—ovarian cancer	0.000415	0.00052	CcSEcCtD
Brimonidine—Nausea—Doxorubicin—ovarian cancer	0.000393	0.000493	CcSEcCtD
